Dear Subscriber, Due to the new Canadian Anti-Spam Law becoming effective July 1st, we will no longer be able to send you important information from Pharmaceutical Technology Europe via email, including the Pharmaceutical Technology Europe and/or the Pharmaceutical Technology Europe digital edition unless we receive your updated consent no later than June 30, 2014. Please click here to confirm your request to continue receiving our emails, and to update the information we currently have for you in our database. And remember, you can withdraw your consent at any time. Sincerely, Pharmaceutical Technology Europe Questions? Refer to our Privacy Policy or Contact Us.